Brian M. Keyser

1.0k total citations
36 papers, 710 citations indexed

About

Brian M. Keyser is a scholar working on Molecular Biology, Plant Science and Physiology. According to data from OpenAlex, Brian M. Keyser has authored 36 papers receiving a total of 710 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 10 papers in Plant Science and 8 papers in Physiology. Recurrent topics in Brian M. Keyser's work include Ion channel regulation and function (9 papers), Pesticide Exposure and Toxicity (9 papers) and Carcinogens and Genotoxicity Assessment (8 papers). Brian M. Keyser is often cited by papers focused on Ion channel regulation and function (9 papers), Pesticide Exposure and Toxicity (9 papers) and Carcinogens and Genotoxicity Assessment (8 papers). Brian M. Keyser collaborates with scholars based in United States, United Kingdom and Denmark. Brian M. Keyser's co-authors include James T. Taylor, Lüping Huang, John Bondo Hansen, Betty Benton, Radharaman Ray, Hean Zhuang, Dana R. Anderson, David S. Ragsdale, Min Zhang and Wesley W. Holmes and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and The FASEB Journal.

In The Last Decade

Brian M. Keyser

34 papers receiving 702 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brian M. Keyser United States 14 386 165 119 76 74 36 710
Salil Srivastava United Kingdom 12 420 1.1× 113 0.7× 49 0.4× 137 1.8× 50 0.7× 19 981
B. Dienes Hungary 19 525 1.4× 188 1.1× 47 0.4× 175 2.3× 33 0.4× 57 930
Neal S. Gould United States 14 494 1.3× 117 0.7× 74 0.6× 288 3.8× 144 1.9× 19 1.1k
Liyan Hou China 21 495 1.3× 256 1.6× 53 0.4× 259 3.4× 133 1.8× 60 1.4k
Xiaoyun Ma China 15 350 0.9× 109 0.7× 49 0.4× 40 0.5× 19 0.3× 46 600
Dietrich O. Ruehlmann Canada 8 308 0.8× 79 0.5× 22 0.2× 111 1.5× 68 0.9× 10 558
Dan Lou China 17 411 1.1× 122 0.7× 53 0.4× 51 0.7× 58 0.8× 48 829
Nihar R. Pandey Canada 17 451 1.2× 95 0.6× 33 0.3× 163 2.1× 20 0.3× 22 976
Bei Zhang China 15 242 0.6× 87 0.5× 36 0.3× 95 1.3× 33 0.4× 35 853
Mónika Gönczi Hungary 17 504 1.3× 145 0.9× 27 0.2× 100 1.3× 32 0.4× 34 819

Countries citing papers authored by Brian M. Keyser

Since Specialization
Citations

This map shows the geographic impact of Brian M. Keyser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian M. Keyser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian M. Keyser more than expected).

Fields of papers citing papers by Brian M. Keyser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian M. Keyser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian M. Keyser. The network helps show where Brian M. Keyser may publish in the future.

Co-authorship network of co-authors of Brian M. Keyser

This figure shows the co-authorship network connecting the top 25 collaborators of Brian M. Keyser. A scholar is included among the top collaborators of Brian M. Keyser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian M. Keyser. Brian M. Keyser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vaughan, Hannah J., Rui Yang, Brian M. Keyser, et al.. (2025). Intracellular Nanodelivery of DNA with Enzyme-Degradable and pH-Responsive Peptide Dendrons. Biomacromolecules. 26(6). 3410–3422.
2.
Makena, Patrudu, Linsey E. Haswell, Michael McEwan, et al.. (2025). An adverse outcome pathway for cigarette smoke-mediated oxidative stress in plaque formation. Frontiers in Toxicology. 7. 1554747–1554747.
3.
Jin, Tao, Brian M. Keyser, Ian M. Fearon, et al.. (2024). Evaluation of environmental emissions from glo heated tobacco products and combustible Cigarettes. Environmental Advances. 17. 100580–100580. 2 indexed citations
4.
Keyser, Brian M., et al.. (2024). Evaluation of Cytotoxicity and Oxidative Stress of Whole Aerosol from Vuse Alto ENDS Products. Toxics. 12(2). 129–129. 1 indexed citations
5.
Keyser, Brian M., et al.. (2024). In vitro toxicological evaluation of pouched portioned oral nicotine products. SHILAP Revista de lepidopterología. 6. 1452274–1452274. 1 indexed citations
7.
Keyser, Brian M., et al.. (2023). Part two: an unblinded, parallel, randomized study to assess nicotine pharmacokinetics of four Vuse Solo ENDS flavors in smokers. Scientific Reports. 13(1). 8894–8894. 1 indexed citations
8.
Keyser, Brian M., et al.. (2023). In vitro permeation of nicotine and tobacco specific nitrosamines from smokeless tobacco product extracts in a 3D buccal tissue model. Toxicology Letters. 392. 36–45. 1 indexed citations
10.
Fields, Wanda, Anna G. Maione, Brian M. Keyser, & Betsy Bombick. (2017). Characterization and Application of the VITROCELL VC1 Smoke Exposure System and 3D EpiAirway Models for Toxicological and e-Cigarette Evaluations. 3(1). 68–83. 34 indexed citations
11.
Keyser, Brian M., et al.. (2015). Transient receptor potential (TRP) channels as a therapeutic target for intervention of respiratory effects and lethality from phosgene. Toxicology Letters. 244. 21–27. 16 indexed citations
12.
Kanjilal, Baishali, et al.. (2014). Differentiated NSC-34 cells as anin vitrocell model for VX. Toxicology Mechanisms and Methods. 24(7). 488–494. 5 indexed citations
13.
Keyser, Brian M., John P. Petrali, Betty Benton, et al.. (2013). Morphological and functional differentiation in BE(2)-M17 human neuroblastoma cells by treatment with Trans-retinoic acid. BMC Neuroscience. 14(1). 49–49. 31 indexed citations
14.
Keyser, Brian M., Eric W. Nealley, Wesley W. Holmes, et al.. (2012). Postexposure Application of Fas Receptor Small-Interfering RNA to Suppress Sulfur Mustard–Induced Apoptosis in Human Airway Epithelial Cells: Implication for a Therapeutic Approach. Journal of Pharmacology and Experimental Therapeutics. 344(1). 308–316. 11 indexed citations
15.
Ray, Radharaman, Cynthia M. Simbulan‐Rosenthal, Brian M. Keyser, et al.. (2010). Sulfur mustard induces apoptosis in lung epithelial cells via a caspase amplification loop. Toxicology. 271(3). 94–99. 26 indexed citations
16.
Taylor, James T., Lüping Huang, Jonathan E. Pottle, et al.. (2008). Selective blockade of T-type Ca2+ channels suppresses human breast cancer cell proliferation. Cancer Letters. 267(1). 116–124. 88 indexed citations
17.
Li, Ming, John Bondo Hansen, Lüping Huang, Brian M. Keyser, & James T. Taylor. (2006). Towards Selective Antagonists of T-Type Calcium Channels: Design, Characterization and Potential Applications of NNC 55-0396. Cardiovascular Drug Reviews. 23(2). 173–196. 52 indexed citations
18.
Zeng, Xiangbin, Brian M. Keyser, Ming Li, & Suresh C. Sikka. (2005). T–Type (α1G) Low Voltage–Activated Calcium Channel Interactions with Nitric Oxide–Cyclic Guanosine Monophosphate Pathway and Regulation of Calcium Homeostasis in Human Cavernosal Cells. The Journal of Sexual Medicine. 2(5). 620–633. 13 indexed citations
19.
Huang, Lüping, Arin Bhattacharjee, James T. Taylor, et al.. (2004). [Ca2+]i regulates trafficking of Cav1.3 (α1D Ca2+ channel) in insulin-secreting cells. American Journal of Physiology-Cell Physiology. 286(2). C213–C221. 15 indexed citations
20.
Huang, Lüping, Brian M. Keyser, Tina M. Tagmose, et al.. (2004). NNC 55-0396 [(1 S,2 S)-2-(2-(N-[(3-Benzimidazol-2-yl)propyl]-N-methylamino)ethyl)-6-fluoro-1,2,3,4-tetrahydro-1-isopropyl-2-naphtyl cyclopropanecarboxylate dihydrochloride]: A New Selective Inhibitor of T-Type Calcium Channels. Journal of Pharmacology and Experimental Therapeutics. 309(1). 193–199. 145 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026